Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Biogen Inc. (NASDAQ:BIIB)

Paying users zone. Data is hidden behind: .


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

Biogen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Current portion of notes payable
Taxes payable
Accounts payable
Revenue-related reserves for discounts and allowances
Employee compensation and benefits
Collaboration expenses
Royalties and licensing fees
Current portion of contingent consideration obligations
Construction in progress
Accrued TECFIDERA litigation settlement charges
Other
Accrued expenses and other
Current liabilities
Notes payable, excluding current portion
Deferred tax liability
Long-term operating lease liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, par value $0.001 per share
Common stock, par value $0.0005 per share
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Treasury stock, at cost
Total Biogen Inc. shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Biogen Inc.’s current liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Biogen Inc.’s long-term liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Biogen Inc.’s total liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 and from 2018 to 2019.
Total Biogen Inc. shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Biogen Inc.’s total Biogen Inc. shareholders’ equity as a percentage of total liabilities and equity decreased from 2017 to 2018 and from 2018 to 2019.